A new approach to the management of diabetic macular edema.
Schachat
Andrew P
AP
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D003930:Diabetic Retinopathy / Q000628:therapy*; D006801:Humans; D017075:Laser Coagulation; D008269:Macular Edema / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D000069579:Ranibizumab; D019233:Retreatment; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000627:therapeutic use; D014792:Visual Acuity / Q000502:physiology
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014222:Triamcinolone Acetonide; D000069579:Ranibizumab